Joinn 昭衍新药
11 significant filings since 29 May 2026: 9 on equity incentive, 1 on dividend and 1 on major holder selling. The latest, on 24 Jul 2026: 昭衍新药2026年A股限制性股票激励计划授予结果公告.
自 29 May 2026 起有 11 份重大公告：equity incentive 9 份、dividend 1 份、major holder selling 1 份。最新一份（24 Jul 2026）：昭衍新药2026年A股限制性股票激励计划授予结果公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 13 Sep 2024 | 国信证券 | 彭思宇,张佳博 | Buy 买入 | ▼ | Outperform 增持 |
| 18 Jul 2023 | 民生证券 | 王班 | Buy 买入 | ▼ | Outperform 增持 |
| 17 Jan 2023 | 中邮证券 | 周豫,乔露阳 | Outperform 增持 | ▲ | Buy 买入 |
| 2 Sep 2020 | 万联证券 | 姚文 | Outperform 增持 | ▲ | Buy 买入 |
| 30 Apr 2020 | 华金证券 | 周新明,王睿 | Outperform 增持 | ▲ | Buy 买入 |
| 13 Apr 2020 | 中银证券 | 张威亚,邓周宇 | Outperform 增持 | ▲ | Buy 买入 |
| 30 Oct 2018 | 中银国际 | 张威亚,邓周宇,柴博,高睿婷 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 国信证券 | 彭思宇,陈曦炳 | Outperform 增持 | 3 Sep 2026 | 2 | — |
| 中邮证券 | 盛丽华,辛家齐 | Buy 买入 | 5 Aug 2026 | 2 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 4 reports. 每行为该券商近十二个月的最新研报；4 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。